Profiel
James Scott Whitehurst formerly worked at Amgen, Inc., as Vice President-Finance & Operations from 2008 to 2016, XBiotech, Inc., as Chief Financial Officer, Elanco Tiergesundheit AG, as Chief Financial Officer from 2005 to 2006, and Keane Consulting, Inc., as Chief Financial Officer from 2005 to 2006.
Eerdere bekende functies van James Scott Whitehurst
| Bedrijven | Functie | Einde |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01-04-2016 |
| Keane Consulting, Inc. | Financieel Directeur/CFO | 01-01-2006 |
Elanco Tiergesundheit AG
 Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Financieel Directeur/CFO | 01-01-2006 |
| XBIOTECH INC. | Financieel Directeur/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| XBIOTECH INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Keane Consulting, Inc. | |
Elanco Tiergesundheit AG
Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Health Technology |
